Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.
scientific article published in January 2018
Author/s
author: Maryna Krawczuk-Rybak, Katarzyna Drabko, Tomasz Ociepa, Katarzyna Pawelec, Danuta Januszkiewicz-Lewandowska, Marek Ussowicz, Blanka Rybka, Renata Ryczan-Krawczyk, Krzysztof Kałwak, Agnieszka Zaucha-Prazmo, Wanda Badowska, Andrzej Koltan, Katarzyna Musiol, Katarzyna Mycko
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.